RDG
READ-GENE
NEWCONNECT
LISTED
Shareholders
as of September 20, 2026 · source: notifications under Art. 69 of the Offering Act · 3 entities above 5%
FREE FLOAT
The portion of capital not covered by notifications above 5% — its composition is not publicly known.
19.84%
—
LARGEST STAKE
67.06%
Gen-Pat-Med Sp. z o.o.
TOP 3 CONCENTRATION
Combined stake of the three largest shareholders above the 5% threshold.
80.16%
3 entities above 5%
LATEST CHANGE
—
no notification history
Ownership structure
stakes per latest notifications
SHAREHOLDERS ≥5% 80.16%
FREE FLOAT 19.84%
HOLDER
STAKE
SHARES
VOTES
NOTIFICATION
Gen-Pat-Med Sp. z o.o.
67.06%
7,905,875
71.79%
August 16, 2026
Jan Lubiński
7.16%
843,856
6.66%
August 16, 2026
Adamed Sp. z o.o.
5.94%
700,000
6.36%
August 16, 2026
Other
19.84%
—
15.19%
—
Gen-Pat-Med Sp. z o.o.
67.06%
7,905,875 shares · notification August 16, 2026
Jan Lubiński
7.16%
843,856 shares · notification August 16, 2026
Adamed Sp. z o.o.
5.94%
700,000 shares · notification August 16, 2026
Other
19.84%
— · composition undisclosed
Notification history
crossings above/below the 5% / 10% / 20% thresholdsNo notification history recorded for this company.
History is built from art. 69 notifications — we have not recorded any yet.
Capital and votes
Number of shares
—
ISIN
PLRADGN00014
Sector
Biotechnologia
Market
NEWCONNECT
Country
PL
Listing date
May 17, 2026
Where this data comes from
The structure is built from notifications shareholders file after crossing 5%, 10%, 15%, 20%, 25%, 33%, 50%, 75% and 90% of votes.
Below 5% there is no disclosure obligation, so the remaining capital is shown collectively as free float — its composition is not publicly known.
Stakes are not updated in real time. The date next to each entity is its last notification date, not today's date.